Grantham Mayo Van Otterloo & Co. LLC acquired a new stake in Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 18,386 shares of the business services provider's stock, valued at approximately $790,000.
Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in shares of Genpact by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider's stock valued at $728,539,000 after buying an additional 61,376 shares during the period. Victory Capital Management Inc. raised its stake in shares of Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock valued at $423,205,000 after purchasing an additional 1,511,790 shares during the period. Franklin Resources Inc. lifted its holdings in shares of Genpact by 1.3% in the fourth quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider's stock valued at $180,560,000 after purchasing an additional 55,771 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Genpact by 3.6% during the fourth quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider's stock worth $170,175,000 after buying an additional 133,938 shares during the period. Finally, JPMorgan Chase & Co. raised its position in Genpact by 8.7% in the 4th quarter. JPMorgan Chase & Co. now owns 3,400,636 shares of the business services provider's stock valued at $146,057,000 after buying an additional 271,295 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Insider Activity
In related news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 2.80% of the company's stock.
Genpact Stock Performance
G stock traded up $0.48 during mid-day trading on Monday, hitting $47.78. 132,813 shares of the company were exchanged, compared to its average volume of 1,506,372. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $56.76. The business has a 50 day simple moving average of $51.00 and a 200-day simple moving average of $45.83. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $8.39 billion, a PE ratio of 16.82, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date was Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 1.42%. Genpact's payout ratio is currently 23.94%.
Analyst Ratings Changes
G has been the topic of a number of recent research reports. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Mizuho raised their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Needham & Company LLC raised their target price on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Six analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $48.44.
View Our Latest Stock Analysis on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report